CRF Connect Logo

Structural

Tricuspid/Pulmonic Valve Intervention Learning Series

Tricuspid Regurgitation - Clinical Trials & Science

Advertisement

Structural >
Tricuspid Regurgitation - Clinical Trials & Science

Episodes

Patient Reported Outcomes in National Registries: Why and How?
Patient Reported Outcomes in National Registries: Why and How?
22 min.
Why We Need a "Toolbox" Approach for the Tricuspid Valve
Why We Need a "Toolbox" Approach for the Tricuspid Valve
9 min.
Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?
Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?
17 min.
Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?
Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?
8 min.
The Compelling Case for Transcatheter Tricuspid Therapies
The Compelling Case for Transcatheter Tricuspid Therapies
15 min.
Topline Results from the TRISCEND II Transcatheter Tricuspid Valve Replacement Trial
Topline Results from the TRISCEND II Transcatheter Tricuspid Valve Replacement Trial
14 min.
Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial
Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial
7 min.
Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!
Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!
11 min.
Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!
Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!
6 min.
RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment
RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment
9 min.
The Importance of Baseline Hemodynamics and Tricuspid Anatomy
The Importance of Baseline Hemodynamics and Tricuspid Anatomy
7 min.
T-TEER - TRILUMINATE
T-TEER - TRILUMINATE
7 min.
Real World TTVI Registries: Is There Concordance With the Randomized Trials?
Real World TTVI Registries: Is There Concordance With the Randomized Trials?
18 min.
Assessing Functional Status and Predicting Clinical Improvement
Assessing Functional Status and Predicting Clinical Improvement
7 min.
Transcatheter Tricuspid Valve Replacement - TRISCEND II
Transcatheter Tricuspid Valve Replacement - TRISCEND II
7 min.
Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy
Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy
14 min.
The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?
The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?
13 min.
TRISCEND II: Understanding the Study Design and Interpreting the Results
TRISCEND II: Understanding the Study Design and Interpreting the Results
8 min.
The Importance of Patient Reported Outcomes in TR Clinical Studies
The Importance of Patient Reported Outcomes in TR Clinical Studies
14 min.
Experience-Based Lessons Learned from Real World T-TEER Cases
Experience-Based Lessons Learned from Real World T-TEER Cases
17 min.
Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives
Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives
15 min.
Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits!
Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits!
15 min.
Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes
Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes
7 min.
What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly
What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly
13 min.
Can We Predict RV Failure After Tricuspid Intervention?
Can We Predict RV Failure After Tricuspid Intervention?
13 min.
Orthotopic TTVR: What Have We Learned From the EFS studies
Orthotopic TTVR: What Have We Learned From the EFS studies
14 min.
Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial
Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial
20 min.
TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation
TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation
22 min.
A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results
A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results
7 min.
One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study
One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study
9 min.
The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update
The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update
13 min.
Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)
Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)
12 min.
TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI
TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI
13 min.
Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study
Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study
13 min.
PROs are a Powerful Endpoint in TR Interventional Trials
PROs are a Powerful Endpoint in TR Interventional Trials
8 min.
TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation
TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation
18 min.
Current Clinical Evidence Following TR Interventions
Current Clinical Evidence Following TR Interventions
20 min.
Case Resolution: A Patient With Severe TR and Limited Therapeutic Options
Case Resolution: A Patient With Severe TR and Limited Therapeutic Options
16 min.
First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial
First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial
13 min.
The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)
The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)
22 min.
First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)
First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)
7 min.
The VDyne TTVR System: Early Human Clinical Results
The VDyne TTVR System: Early Human Clinical Results
17 min.
PASCAL T-TEER Clinical Trial Update (CLASP IITR)
PASCAL T-TEER Clinical Trial Update (CLASP IITR)
7 min.
Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)
Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)
5 min.
The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort
The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort
7 min.
Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials
Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials
8 min.
Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients
Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients
8 min.
Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy
Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy
9 min.